Ming Yue Li

1.1k total citations
30 papers, 884 citations indexed

About

Ming Yue Li is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Ming Yue Li has authored 30 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Ming Yue Li's work include Inflammasome and immune disorders (6 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Ming Yue Li is often cited by papers focused on Inflammasome and immune disorders (6 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Ming Yue Li collaborates with scholars based in China, North Korea and United States. Ming Yue Li's co-authors include Juan Ma, Xuejun Jin, Hong Xiang Zuo, Yue Xing, Lian Xun Piao, Zhi Hong Zhang, Jing Ying Wang, Guang Xu, Chunliu Mi and Cheng Hua Jin and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, British Journal of Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Ming Yue Li

28 papers receiving 879 citations

Peers

Ming Yue Li
Sen Lian South Korea
Ji‐Ye Kee South Korea
Tina H. Ong Singapore
Te-Mao Li Taiwan
Anqi Zeng China
Ming Yue Li
Citations per year, relative to Ming Yue Li Ming Yue Li (= 1×) peers Yi‐Ching Chuang

Countries citing papers authored by Ming Yue Li

Since Specialization
Citations

This map shows the geographic impact of Ming Yue Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Yue Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Yue Li more than expected).

Fields of papers citing papers by Ming Yue Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Yue Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Yue Li. The network helps show where Ming Yue Li may publish in the future.

Co-authorship network of co-authors of Ming Yue Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Yue Li. A scholar is included among the top collaborators of Ming Yue Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Yue Li. Ming Yue Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yi, Tai, Hong Xiang Zuo, Yue Xing, et al.. (2025). Formononetin ameliorates DSS-induced colitis by inhibiting the MAPK/PPAR-γ/NF-κB/ROS signaling pathways. Toxicology and Applied Pharmacology. 496. 117239–117239. 6 indexed citations
3.
Wang, Yuhan, Yi‐Yin Tai, Jing Han, et al.. (2025). Cucurbitacin B alleviates DSS-induced experimental colitis by targeting ZNF70 to suppress the NLRP3/STAT3 signaling axis. Inflammopharmacology. 33(9). 5451–5469.
4.
Liu, Xin, Yi‐Yin Tai, Jing Han, et al.. (2024). Parthenolide Inhibits Synthesis and Promotes Degradation of Programmed Cell Death Ligand 1 and Enhances T Cell Tumor-Killing Activity. Journal of Agricultural and Food Chemistry. 72(38). 21013–21029. 1 indexed citations
5.
Song, Lei, Yi‐Yin Tai, Jia Li, et al.. (2024). Mollugin inhibits IL-1β production by reducing zinc finger protein 91-regulated Pro-IL-1β ubiquitination and inflammasome activity. International Immunopharmacology. 145. 113757–113757.
6.
Ri, MyongHak, Yue Xing, Hong Xiang Zuo, et al.. (2023). Regulatory mechanisms of natural compounds from traditional Chinese herbal medicines on the microglial response in ischemic stroke. Phytomedicine. 116. 154889–154889. 20 indexed citations
7.
Zhong, Yi, Ming Yue Li, Yi‐Yin Tai, et al.. (2023). Galangin inhibits programmed cell death-ligand 1 expression by suppressing STAT3 and MYC and enhances T cell tumor-killing activity. Phytomedicine. 116. 154877–154877. 10 indexed citations
8.
Wang, Jing Ying, Ming Yue Li, Zhi Hong Zhang, et al.. (2021). Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation. The Journal of Nutritional Biochemistry. 100. 108899–108899. 46 indexed citations
9.
Jin, Yong Jun, Hong Xiang Zuo, Ming Yue Li, et al.. (2021). Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo. Frontiers in Pharmacology. 12. 774231–774231. 14 indexed citations
10.
Wang, Jing Ying, Yue Xing, Ming Yue Li, et al.. (2021). Panaxadiol inhibits IL-1β secretion by suppressing zinc finger protein 91-regulated activation of non-canonical caspase-8 inflammasome and MAPKs in macrophages. Journal of Ethnopharmacology. 283. 114715–114715. 13 indexed citations
11.
Sun, Tong, Ming Yue Li, Zhi Hong Zhang, et al.. (2021). Usnic acid suppresses cervical cancer cell proliferation by inhibiting PD‐L1 expression and enhancing T‐lymphocyte tumor‐killing activity. Phytotherapy Research. 35(7). 3916–3935. 37 indexed citations
12.
Zhong, Yi, Zhi Hong Zhang, Jing Ying Wang, et al.. (2021). Zinc finger protein 91 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation. Toxicology Letters. 356. 75–88. 10 indexed citations
14.
Yang, Ao, Ming Yue Li, Zhi Hong Zhang, et al.. (2020). Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity. Journal of Ethnopharmacology. 273. 113598–113598. 42 indexed citations
15.
Wang, Jing Ying, Zhe Wang, Ming Yue Li, et al.. (2018). Dictamnine promotes apoptosis and inhibits epithelial-mesenchymal transition, migration, invasion and proliferation by downregulating the HIF-1α and Slug signaling pathways. Chemico-Biological Interactions. 296. 134–144. 41 indexed citations
16.
Xing, Yue, Chunliu Mi, Zhe Wang, et al.. (2018). Fraxinellone has anticancer activity in vivo by inhibiting programmed cell death-ligand 1 expression by reducing hypoxia-inducible factor-1α and STAT3. Pharmacological Research. 135. 166–180. 66 indexed citations
17.
Zhang, Zhi Hong, Chunliu Mi, Ke Si Wang, et al.. (2017). Chelidonine inhibits TNF‐α‐induced inflammation by suppressing the NF‐κB pathways in HCT116 cells. Phytotherapy Research. 32(1). 65–75. 50 indexed citations
18.
Hong, Yang, et al.. (2017). Pulmonary Toxicity in Rats Caused by Exposure to Intratracheal Instillation of SiO2 Nanoparticles.. PubMed. 30(4). 264–279. 33 indexed citations
19.
Mi, Chunliu, Juan Ma, Ke Si Wang, et al.. (2017). Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways. Journal of Ethnopharmacology. 203. 27–38. 99 indexed citations
20.
Li, Ming Yue, Kefeng Wu, Michael K.Y. Hsin, et al.. (2010). Anticancer efficacy of 5F in NNK-induced lung cancer development of A/J mice and human lung cancer cells. Journal of Molecular Medicine. 88(12). 1265–1276. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026